Conventional-dose Chemotherapy Combined with Immunotherapy Group:None
Sponsors
The First Affiliated Hospital of Sun Yat-Sen University, Huashan Hospital Fudan University
Conditions
Esophageal squamous cell carcinomagastric cancer
Unknown Phase
A retrospective real-world study evaluating the safety and efficacy of neoadjuvant PD-1 blockade plus half-dose chemotherapy in patients aged 70 years and older with esophageal squamous cell carcinoma
Active, not recruitingChiCTR2500100092
Start: 2024-01-01Updated: 2025-04-07
Real-World Retrospective Study: Efficacy Evaluation of Different Chemotherapy Regimens Alone or in Combination with Immunotherapy in Patients with Advanced Gastric Cancer
Active, not recruitingChiCTR2600117542
Start: 2026-01-31Updated: 2026-02-02